Jianxia Chen

2.4k total citations
52 papers, 1.2k citations indexed

About

Jianxia Chen is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Jianxia Chen has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Immunology and 10 papers in Epidemiology. Recurrent topics in Jianxia Chen's work include Tuberculosis Research and Epidemiology (8 papers), interferon and immune responses (6 papers) and NF-κB Signaling Pathways (5 papers). Jianxia Chen is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), interferon and immune responses (6 papers) and NF-κB Signaling Pathways (5 papers). Jianxia Chen collaborates with scholars based in China, United States and Germany. Jianxia Chen's co-authors include Baoxue Ge, Mark D. Soucek, Haipeng Liu, William J. Simonsick, Feng Liu, Ruijuan Zheng, Qin Liu, Ke Lan, Qingyuan Zhu and Yilong Zhou and has published in prestigious journals such as Nature, Nature Communications and Nature Immunology.

In The Last Decade

Jianxia Chen

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianxia Chen China 20 535 284 232 210 196 52 1.2k
Christina Kriegel United States 17 891 1.7× 460 1.6× 259 1.1× 81 0.4× 290 1.5× 20 2.3k
Perla Filippini Italy 16 260 0.5× 164 0.6× 110 0.5× 42 0.2× 100 0.5× 32 813
Liya Ye China 23 1.3k 2.4× 239 0.8× 308 1.3× 221 1.1× 140 0.7× 58 2.3k
Kelly Tsang United States 16 608 1.1× 159 0.6× 72 0.3× 60 0.3× 66 0.3× 24 1.6k
Qilin Li China 23 478 0.9× 254 0.9× 107 0.5× 135 0.6× 61 0.3× 59 1.4k
Dahai Zheng China 23 446 0.8× 421 1.5× 204 0.9× 120 0.6× 234 1.2× 43 1.5k
Piotr Bielecki Germany 20 929 1.7× 387 1.4× 91 0.4× 152 0.7× 156 0.8× 30 1.7k
Emmanuel A. Ho Canada 22 610 1.1× 133 0.5× 108 0.5× 164 0.8× 73 0.4× 52 1.5k
Amanda E. Brooks United States 19 837 1.6× 123 0.4× 86 0.4× 72 0.3× 81 0.4× 69 1.8k
Torbjörn Bengtsson Sweden 30 564 1.1× 543 1.9× 66 0.3× 78 0.4× 139 0.7× 79 2.2k

Countries citing papers authored by Jianxia Chen

Since Specialization
Citations

This map shows the geographic impact of Jianxia Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianxia Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianxia Chen more than expected).

Fields of papers citing papers by Jianxia Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianxia Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianxia Chen. The network helps show where Jianxia Chen may publish in the future.

Co-authorship network of co-authors of Jianxia Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jianxia Chen. A scholar is included among the top collaborators of Jianxia Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianxia Chen. Jianxia Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Hang, Changyong Hu, Jianxia Chen, et al.. (2025). Development of antibody drug conjugates targeting epithelial membrane protein 2-highly expressed lung cancer. Cell Death and Disease. 16(1). 771–771.
2.
Dong, Zhixiang, Yihai Wang, Jianxia Chen, et al.. (2025). Acylsemicarbazide‐Based Supramolecular Liquid Crystal Elastomers: from Molecular Design to Melt‐Processing Actuators. Advanced Functional Materials.
3.
Chen, Jianxia, et al.. (2025). Increased long-term central memory T cells in patients with retreatment pulmonary tuberculosis. Frontiers in Immunology. 16. 1545537–1545537.
4.
Chen, Jianxia, Weijun Zhou, Jian Li, et al.. (2025). Deep learning-based framework for real-time microscopic ghost imaging of live red blood cells. Optics and Lasers in Engineering. 194. 109195–109195. 1 indexed citations
5.
Bai, Yanfeng, Xiaohui Zhu, Jianxia Chen, et al.. (2025). Random mask generation meets latent diffusion: Toward synthetic data for microscopic ghost imaging. Optics & Laser Technology. 192. 114008–114008.
6.
Duan, Yongjia, Mingtong Ma, Liru Li, et al.. (2024). Liquid-liquid phase separation of TRAF6 promotes anti-TB immunity. Science Bulletin. 70(3). 338–341. 1 indexed citations
7.
Qin, Lianhua, Junfang Xu, Jianxia Chen, et al.. (2024). Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growth. eLife. 13. 3 indexed citations
8.
Li, Heng, et al.. (2023). Comparative interleukins and chemokines analysis of mice mesenchymal stromal cells infected with Mycobacterium tuberculosis H37Rv and H37Ra. Archives of Biochemistry and Biophysics. 744. 109673–109673. 4 indexed citations
9.
Chen, Jianxia, Fen Tang, Haohao Li, et al.. (2023). Mycobacterium tuberculosis suppresses APLP2 expression to enhance its survival in macrophage. International Immunopharmacology. 124(Pt B). 111058–111058. 3 indexed citations
10.
Gao, Jiani, Xiangyang Wu, Hang Su, et al.. (2022). CDK inhibitor Palbociclib targets STING to alleviate autoinflammation. EMBO Reports. 23(6). e53932–e53932. 46 indexed citations
11.
Yang, Hong, et al.. (2020). Sirtuin inhibits M. tuberculosis -induced apoptosis in macrophage through glycogen synthase kinase-3β. Archives of Biochemistry and Biophysics. 694. 108612–108612. 19 indexed citations
12.
Yang, Hong, et al.. (2020). Sirt1 activation negatively regulates overt apoptosis in Mtb-infected macrophage through Bax. International Immunopharmacology. 91. 107283–107283. 19 indexed citations
13.
Chen, Jianxia, et al.. (2019). <p>miR-509-5p Downregulation Is Associated With Male Infertility And Acts As A Suppressor In Testicular Germ Cell Tumor Cells Through Targeting MDM2</p>. OncoTargets and Therapy. Volume 12. 10515–10522. 13 indexed citations
14.
Chen, Jianxia, Jun Chen, Fusheng He, et al.. (2019). Design of a Targeted Sequencing Assay to Detect Rare Mutations in Circulating Tumor DNA. Genetic Testing and Molecular Biomarkers. 23(4). 264–269. 5 indexed citations
15.
Liu, Feng, Jianxia Chen, Peng Wang, et al.. (2018). MicroRNA-27a controls the intracellular survival of Mycobacterium tuberculosis by regulating calcium-associated autophagy. Nature Communications. 9(1). 4295–4295. 106 indexed citations
16.
Yang, Hua, Haipeng Liu, Hao Chen, et al.. (2016). G protein-coupled receptor160 regulates mycobacteria entry into macrophages by activating ERK. Cellular Signalling. 28(9). 1145–1151. 9 indexed citations
17.
Zhou, Yilong, Chenxi He, Dapeng Yan, et al.. (2016). The kinase CK1ɛ controls the antiviral immune response by phosphorylating the signaling adaptor TRAF3. Nature Immunology. 17(4). 397–405. 27 indexed citations
18.
Wen-juan, Bai, Haipeng Liu, Qun Ji, et al.. (2014). TLR3 regulates mycobacterial RNA-induced IL-10 production through the PI3K/AKT signaling pathway. Cellular Signalling. 26(5). 942–950. 61 indexed citations
19.
Liu, Haipeng, Zhonghua Liu, Jianxia Chen, et al.. (2013). Induction of CCL8/MCP-2 by Mycobacteria through the Activation of TLR2/PI3K/Akt Signaling Pathway. PLoS ONE. 8(2). e56815–e56815. 26 indexed citations
20.
Liu, Haipeng, Mingcan Yu, Menghui Jiang, et al.. (2010). Association of supervillin with KIR2DL1 regulates the inhibitory signaling of natural killer cells. Cellular Signalling. 23(2). 487–496. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026